Aemetis Inc
$ 1.54
-1.91%
11 Mar - close price
- Market Cap 101,948,000 USD
- Current Price $ 1.54
- High / Low $ 1.59 / 1.49
- Stock P/E N/A
- Book Value -4.69
- EPS -1.52
- Next Earning Report 2026-03-12
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.13 %
- ROE N/A %
- 52 Week High 3.66
- 52 Week Low 1.22
About
Aemetis, Inc. is a biochemical and renewable natural gas and fuels company in North America and India. The company is headquartered in Cupertino, California.
Analyst Target Price
$13.38
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-05 | 2025-11-06 | 2025-08-07 | 2025-05-07 | 2025-03-05 | 2024-11-07 | 2024-08-01 | 2024-05-09 | 2024-03-07 | 2023-11-09 | 2023-08-03 | 2023-05-04 |
| Reported EPS | 0 | -0.37 | -0.41 | -0.47 | -0.3544 | -0.3799 | -0.66 | -0.58 | -0.64 | 0.73 | -0.68 | -0.73 |
| Estimated EPS | -0.1903 | -0.19 | -0.28 | -0.45 | -0.4052 | -0.42 | -0.43 | -0.46 | -0.34 | -0.29 | -0.39 | -0.39 |
| Surprise | 0.1903 | -0.18 | -0.13 | -0.02 | 0.0508 | 0.0401 | -0.23 | -0.12 | -0.3 | 1.02 | -0.29 | -0.34 |
| Surprise Percentage | 100% | -94.7368% | -46.4286% | -4.4444% | 12.537% | 9.5476% | -53.4884% | -26.087% | -88.2353% | 351.7241% | -74.359% | -87.1795% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-12 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.28 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AMTX
2026-03-11 09:52:20
Grantham Mayo Van Otterloo & Co. LLC reduced its stake in Aemetis, Inc (NASDAQ:AMTX) by 39.2% during the third quarter, selling 652,100 shares and now owning 1,011,412 shares worth $2,276,000. Despite this, other institutional investors have recently acquired or increased their positions in the company. Analysts have assigned Aemetis a "Moderate Buy" rating with an average target price of $17.00, although the stock has experienced significant fluctuations over the past year.
2026-03-06 14:52:44
Aemetis, Inc. (NASDAQ: AMTX) announced it will host a conference call on Thursday, March 12, 2026, at 11 am Pacific Time to discuss its fourth-quarter and year-end 2025 earnings. The call will allow attendees to submit questions during a Q&A session. Aemetis is a diversified renewable natural gas and biofuels company headquartered in California.
2026-02-23 11:52:21
Aemetis, Inc. (NASDAQ: AMTX) recently increased its authorized common stock from 80 million to 140 million shares, following stockholder approval, expanding its total authorized capital to 205 million shares. This move provides the company with greater flexibility for future equity issuances, financing, and strategic transactions. Additionally, Aemetis affirmed its ability to sell up to $210 million in common stock through an existing at-the-market offering program, reinforcing its access to equity markets.
2026-02-19 15:27:23
A lobbying disclosure reveals AEMETIS INC. spent $30,000 in Q4 2025 lobbying efforts, specifically on issues related to the Section 45Z production tax credit. Concurrently, an analysis of AMTX stock shows a mixed institutional investor sentiment with 31 firms adding and 47 decreasing their positions, while one analyst firm issued a "Buy" rating.
2026-02-18 17:34:29
Aemetis, Inc. has increased its authorized capital stock from 145 million to 205 million shares by amending its Certificate of Incorporation, aiming to enhance capital flexibility. Shareholder approval was granted for boosting common stock from 80 million to 140 million shares, although a reduction in authorized preferred stock was not approved. The company seeks to strengthen its capital-raising ability, potentially through an existing at-the-market program, which analysts rate as a Hold with a $1.50 price target due to financial performance concerns.
2026-02-07 21:57:26
Aemetis Biogas LLC, a subsidiary of Aemetis, Inc., has extended the deadline for redeeming Series A Preferred Units to April 30, 2026, from the previous December 31, 2025 date. This comes as the company faces significant financial distress with a substantial debt burden and a "WEAK" financial health rating according to InvestingPro. If redemption is not completed, Aemetis Biogas will enter a credit agreement with Protair-X Technologies and Third Eye Capital, involving a high-interest loan and asset guarantees from Aemetis, Inc. and its subsidiaries.
